Recombinant Mycoplasma pneumoniae Cysteine--tRNA ligase (cysS)

What is Mycoplasma pneumoniae Cysteine--tRNA ligase (cysS) and what is its function?

Mycoplasma pneumoniae cysteine--tRNA ligase (cysS), also known as cysteinyl-tRNA synthetase, is an enzyme that catalyzes the attachment of the amino acid cysteine to its cognate tRNA molecule (tRNACys). It belongs to the family of ligases that form carbon-oxygen bonds in aminoacyl-tRNA compounds. The systematic name is L-cysteine:tRNACys ligase (AMP-forming) .

The enzyme catalyzes the following reaction:
ATP + L-cysteine + tRNACys → AMP + diphosphate + L-cysteinyl-tRNACys

This reaction is essential for protein synthesis, ensuring the correct incorporation of cysteine into proteins during translation. The enzyme participates in cysteine metabolism and aminoacyl-tRNA biosynthesis pathways . In the minimal genome of M. pneumoniae (strain ATCC 29342/M129), this enzyme plays a critical role in maintaining translational fidelity .

What expression systems are typically used for recombinant production of M. pneumoniae cysS?

The recombinant production of M. pneumoniae cysS typically employs E. coli expression systems, similar to other M. pneumoniae proteins. Based on established approaches for similar proteins, the recommended methodology includes:

• Gene cloning from M. pneumoniae genomic DNA (typically strain ATCC 29342/M129)

• Insertion into an appropriate expression vector with fusion tags to aid purification

• Transformation into an E. coli expression strain optimized for protein production

A comparable approach is documented for the recombinant production of M. pneumoniae P30 adhesin, which was successfully expressed in E. coli with an N-terminal 6xHis-GST-tag . This tag combination facilitates both purification (via the His-tag) and solubility enhancement (via GST), resulting in highly pure protein (>85%) as confirmed by SDS-PAGE .

For enzymes requiring proper folding, expression conditions often need optimization:

• Lower induction temperatures (16-20°C)

• Reduced IPTG concentrations (0.1-0.5 mM)

• Extended expression times (overnight)

• Co-expression with chaperones if solubility issues arise

How is the activity of recombinant cysS typically measured in laboratory settings?

The enzymatic activity of recombinant M. pneumoniae cysS can be assessed using several established methods that evaluate its ability to charge tRNACys with cysteine:

• ATP-PPi exchange assay:

  • Measures the first step of the aminoacylation reaction (amino acid activation)

  • Detects the ATP-dependent formation of aminoacyl-adenylate

  • Requires [32P]PPi and monitors its incorporation into ATP

• Aminoacylation assay:

  • Directly measures tRNA charging with cysteine

  • Can utilize [35S]cysteine to monitor incorporation into acid-precipitable tRNA

  • Reaction components include purified enzyme, tRNACys, ATP, cysteine, and appropriate buffers

• Pyrophosphate release assay:

  • Non-radioactive alternative using coupled enzymatic reactions

  • Measures the release of pyrophosphate during aminoacylation

  • More suitable for high-throughput screening applications

These assays should be performed under optimal conditions for M. pneumoniae enzymes, which may differ from conditions for orthologs from other organisms. Control reactions without enzyme, without tRNA, or without ATP should be included to confirm specificity.

What structural features characterize M. pneumoniae cysS?

While the search results don't provide M. pneumoniae cysS-specific structural information, general characteristics of cysteinyl-tRNA synthetases and related structures can inform our understanding:

As of late 2007, three structures had been solved for this enzyme class, with PDB accession codes 1LI5, 1LI7, and 1U0B . These structures can serve as templates for homology modeling of M. pneumoniae cysS.

Cysteinyl-tRNA synthetases typically display:

• A Rossmann fold in the catalytic domain for ATP binding

• A dedicated cysteine recognition pocket with specificity-determining residues

• An anticodon binding domain for specific tRNACys recognition

• Active site motifs characteristic of class I aminoacyl-tRNA synthetases

For comparison, the SepCysS enzyme (involved in an alternative pathway for cysteinyl-tRNA formation) interacts with tRNACys through specific structural elements:

• N-terminal extensions that contact the TΨC loop of tRNA

• A helix-loop-helix-loop region that holds the acceptor stem of tRNA via hydrogen bonds and electrostatic interactions

How do tRNA-dependent cysteine biosynthesis pathways differ from direct aminoacylation by cysS?

Two distinct pathways exist for generating cysteinyl-tRNACys:

• Direct pathway (via cysS):

  • Cysteine is directly attached to tRNACys by cysteine--tRNA ligase (cysS)

  • Single-step reaction: ATP + L-cysteine + tRNACys → AMP + PPi + L-cysteinyl-tRNACys

  • Found in most bacteria and eukaryotes

• Indirect pathway (tRNA-dependent):

  • Two-step process involving O-phosphoseryl-tRNA synthetase (SepRS) and Sep-tRNA:Cys-tRNA synthase (SepCysS)

  • Step 1: SepRS attaches O-phosphoserine (Sep) to tRNACys

  • Step 2: SepCysS converts tRNA-bound Sep into cysteine

  • Found in methanogenic archaea and some ancient bacteria

In methanogenic archaea, a third protein (SepCysE) forms a bridge between SepRS and SepCysS, creating a complex called the "transsulfursome" . This complex enables channeling of tRNACys between the active sites of SepRS and SepCysS, enhancing the efficiency of the two-step reaction .

The structural basis for this channeling mechanism has been elucidated through X-ray crystallography, SAXS, and EM studies, revealing that the three domains of SepCysE bind SepRS, SepCysS, and tRNACys, respectively . This arrangement facilitates the consecutive reactions and may reflect an ancient mechanism by which cysteine was originally incorporated into the genetic code .

What challenges must be overcome when expressing and purifying active recombinant M. pneumoniae cysS?

Expressing and purifying active recombinant M. pneumoniae cysS presents several significant challenges requiring systematic optimization:

• Codon usage bias:

  • M. pneumoniae has a distinct codon usage pattern

  • Solution: Codon optimization for E. coli or use of Rosetta strains supplying rare tRNAs

• Protein solubility issues:

  • Aminoacyl-tRNA synthetases often form inclusion bodies when overexpressed

  • Solution: Expression with solubility-enhancing tags (MBP, SUMO, Thioredoxin)

• Maintaining enzymatic activity:

  • Preserving the native conformation during purification

  • Solution: Inclusion of stabilizing agents (glycerol, reducing agents)

• tRNA co-purification:

  • Endogenous E. coli tRNAs may co-purify with the recombinant enzyme

  • Solution: High-salt washes or additional purification steps

A similar approach has been successfully applied to other M. pneumoniae proteins, as demonstrated by the expression of P30 adhesin with an N-terminal 6xHis-GST-tag, which achieved >85% purity .

How can site-directed mutagenesis of recombinant M. pneumoniae cysS provide insights into its catalytic mechanism?

Site-directed mutagenesis of recombinant M. pneumoniae cysS offers a powerful approach to dissect the enzyme's catalytic mechanism and substrate recognition determinants. A comprehensive mutagenesis strategy would target:

• Conserved motifs:

  • HIGH and KMSKS sequences characteristic of class I aminoacyl-tRNA synthetases

  • Methodology: Alanine-scanning mutagenesis followed by kinetic characterization

• Cysteine binding pocket residues:

  • Amino acids predicted to interact with the cysteine substrate

  • Methodology: Conservative substitutions to test specific interactions

• tRNA recognition elements:

  • Residues contacting the anticodon and acceptor stem of tRNACys

  • Methodology: Charge-swap mutations to disrupt specific interactions

Similar approaches have been applied to study tRNA binding in related systems, such as the SepCysE protein which interacts with tRNACys via specific residues in its CTD domain . For example, alanine replacement mutations of residues [(Asn117, Lys118, and Lys119), (Lys122, Lys123, Lys125, and Asn126) and (Lys159, Lys160 and Lys161)] demonstrated their importance in tRNA binding .

Systematic analysis of mutant enzymes would include:

What role might cysS play in M. pneumoniae pathogenesis and host interaction?

While primarily recognized for its role in protein synthesis, cysS could potentially contribute to M. pneumoniae pathogenesis through several mechanisms:

• Potential moonlighting functions:

  • Some aminoacyl-tRNA synthetases perform secondary functions beyond translation

  • Methodology: Protein-protein interaction studies using co-immunoprecipitation or yeast two-hybrid screening

• Connection to adhesion processes:

  • M. pneumoniae pathogenicity depends on adhesins like P30 that enable cytadherence

  • Methodology: Investigation of potential regulatory links between protein synthesis machinery and adhesin expression

• Role in stress response and adaptation:

  • Cysteine metabolism is linked to oxidative stress defense

  • Methodology: Transcriptomic analysis of cysS expression under infection-relevant conditions

• Contribution to minimal genome adaptation:

  • M. pneumoniae strain M129 (ATCC 29342) has evolved a streamlined genome

  • Methodology: Comparative genomics analysis of cysS conservation across Mycoplasma species

The virulence of M. pneumoniae depends on proper expression of adhesins such as P30. Research has shown that mutations affecting P30 expression directly impact cytadherence, and that recombinant expression of wild-type P30 can restore cytadherence in mutants . Similar methodological approaches could be applied to investigate potential links between cysS function and virulence factor expression.

How can recombinant M. pneumoniae cysS be used in developing diagnostic tools for M. pneumoniae infection?

Recombinant M. pneumoniae cysS offers potential applications in improving diagnostic tools for M. pneumoniae infections, addressing current limitations in sensitivity and specificity:

• Serological diagnostics:

  • Recombinant cysS could serve as an antigen in ELISA or immunochromatographic tests (ICTs)

  • Current ICTs for M. pneumoniae show good specificity (92%) but moderate sensitivity (70%)

  • Adding cysS to antigen panels could potentially improve detection performance

• Multiplex antigen approaches:

  • Combining cysS with other M. pneumoniae antigens (P1, P30, MPN456)

  • Research has shown that "the use of chimeric antigens improve the performance of the assays"

  • Recombinant chimeric antigens could "provide the basis for standardized commercial tests for the serodiagnosis of M. pneumoniae diseases"

• PCR-based detection:

  • Species-specific primers targeting unique regions of the cysS gene

  • PCR as a reference standard shows higher sensitivity than culture methods

A comprehensive evaluation of different diagnostic platforms would include:

The pooled sensitivity and specificity for diagnosing M. pneumoniae infection using current ICTs are 0.70 (95% CI: 0.59–0.79) and 0.92 (95% CI: 0.87–0.95), respectively , suggesting room for improvement with additional targets like cysS.

What are the implications of tRNA-dependent cysteine biosynthesis for understanding the evolution of the genetic code?

The existence of two distinct pathways for cysteinyl-tRNA formation—direct charging by cysS and the indirect tRNA-dependent pathway—provides valuable insights into the evolution of the genetic code:

• Ancient origins:

  • The indirect pathway (using SepRS and SepCysS) may represent an ancestral mechanism for incorporating cysteine into proteins

  • The channeling mechanism in the transsulfursome complex "may reflect the mechanism that cysteine was originally added into genetic code"

• Structural adaptations:

  • In methanogens, the SepCysE protein connects SepRS and SepCysS to form the transsulfursome complex

  • This architecture "enables a global long-range channeling of tRNACys between SepRS and SepCysS distant active sites"

  • The central region of SepCysE(CTD) interacts with the TΨC and D loops of tRNACys through complementary surfaces

• Translational fidelity mechanisms:

  • The indirect pathway may have evolved to "prevent challenge of translational fidelity"

  • The channeling of charged tRNA protects the activated amino acid and prevents misincorporation

• Co-evolution of metabolism and translation:

  • The two pathways reflect different strategies for connecting amino acid metabolism to the translation apparatus

  • Understanding these connections provides insights into how the genetic code expanded to include cysteine

Research methodologies to investigate these evolutionary implications include:

• Ancestral sequence reconstruction

• Biochemical characterization of evolutionarily diverse cysS enzymes

• Structural studies of the tRNA recognition determinants

• Comparative genomics of direct versus indirect pathways across the tree of life

How does macrolide resistance in M. pneumoniae affect research approaches to studying cysS?

The high prevalence of macrolide resistance in M. pneumoniae has important implications for research on cysS and other cellular components:

• Resistance mechanisms:

  • Macrolide resistance is primarily due to mutations in the 23S rRNA gene (2063 or 2064 position)

  • In a Japanese study, 76.7% of M. pneumoniae isolates showed these mutations

  • Research methodology: PCR detection of resistance mutations parallel to cysS studies

• Strain selection considerations:

  • When working with clinical isolates, researchers should characterize their macrolide resistance profile

  • M. pneumoniae strain M129 (ATCC 29342) serves as a reference strain

• Treatment response implications:

  • Among patients treated with macrolides, treatment outcomes differed based on resistance status:

    • Median time to defervescence: 2 days (susceptible) vs. 4 days (resistant)

    • Frequency of antibiotic change: 0% (susceptible) vs. 52.6% (resistant)

• Impact on research protocols:

  • When designing experiments with live M. pneumoniae, researchers should consider:

    • Potential effects of antibiotic selection markers

    • Growth medium components that might select for resistance

    • Strain stability throughout experimental procedures

• Diagnostic considerations:

  • Research on cysS as a diagnostic target should account for potential genetic variation in resistant strains

  • Primers or antibodies should target conserved regions unlikely to be affected by resistance mutations

What methodological considerations are important when comparing cysS with threonyl-tRNA synthetase and other aminoacyl-tRNA synthetases?

When designing comparative studies between cysS and other aminoacyl-tRNA synthetases like threonyl-tRNA synthetase (TRS), several methodological considerations are crucial:

• Structural domain comparison:

  • TRS contains specialized domains like UNE-T (residues 1-80) that mediate specific protein interactions

  • Methodology: Generate plasmids encoding different functional domains based on published structures

  • Analysis technique: Co-immunoprecipitation to identify interaction partners, as demonstrated for TRS domains

• tRNA recognition specificity:

  • Different aminoacyl-tRNA synthetases employ distinct recognition strategies

  • For SepCysS (related to cysS function), specific interactions with tRNACys include:

    • N-terminal chain extending over the stem of the TΨC loop with residues (Asn19, Asp21, Asn25) interacting with G51, C62, and C63

    • A helix-loop-helix-loop region (Pro333–Glu368) holding the acceptor stem of tRNA

• Evolutionary classification considerations:

  • Aminoacyl-tRNA synthetases are divided into class I and class II enzymes

  • Cysteinyl-tRNA synthetase belongs to class I, while threonyl-tRNA synthetase is class II

  • This affects experimental design for inhibitor studies and structural analyses

• Experimental binding assays:

  • Isothermal titration calorimetry (ITC) is effective for quantifying direct interactions

  • As demonstrated for TRS UNE-T domain with 4EHP, binding can be fitted to a 1:1 binding model

• Functional diversification:

  • Some aminoacyl-tRNA synthetases have evolved non-canonical functions

  • TRS has been shown to interact with translation initiation machinery through specific domains

  • Methodology: Domain deletion and chimeric protein construction to map functional regions

When comparing enzymatic parameters between different aminoacyl-tRNA synthetases, standardized assay conditions are essential to generate meaningful comparative data, accounting for differences in optimal pH, temperature, and ionic requirements.